TERNS
Live / Allowed — Published for opposition (as of 10 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 08 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99328453
- Mark type
- Design + words
- Filed
- 08 Aug 2025
- Published for opposition
- 10 Feb 2026
- Attorney of record
- Tiffany D. Gehrke
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, small-molecule drugs for the treatment of cancer, metabolic disorders, and endocrine disorders; Pharmaceutical and biologic preparations for use in the treatment of oncology-related diseases and disorders; Pharmaceutical and biologic preparations for use in the treatment of metabolic-related diseases and disorders; Pharmaceutical and biologic preparations for use in the treatment of endocrine-related diseases and disorders; Pharmaceutical and biologic preparations for use in the treatment of diabetes and obesity-related diseases and disorders; Peptides for pharmaceutical purposes, namely, for the treatment of cancer, metabolic disorders, and endocrine disorders
- Class 042 — Scientific and technological services: Pharmaceutical and biologic drug development services, namely, development of small-molecule drugs for use in humans; Pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of oncology-related diseases and disorders; Pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of metabolic-related diseases and disorders; Pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of endocrine-related diseases and disorders; Pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of diabetes and obesity-related diseases and disorders; Research and development services in the field of pharmaceutical and biologic preparations; Research and development services in the field of oncology-related diseases and disorders; Research and development services in the field of metabolic-related diseases and disorders; Research and development services in the field of endocrine-related diseases and disorders; Research and development services in the fields of diabetes and obesity-related diseases and disorders; Research and development services in the field of peptide pharmaceutical preparations; Providing medical and scientific research information in the field of small-molecule drugs; Providing medical and scientific research information in the field of clinical trials and post-market trials; Providing medical and scientific research information in the field of oncology, metabolic, endocrine, diabetes, and obesity-related diseases and disorders
Owner
- Terns Pharmaceuticals, Inc., Foster City, CA, US
- Terns Pharmaceuticals, Inc., Foster City, CA, US
Prosecution history
- 10 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Feb 2026 — PUBLISHED FOR OPPOSITION
- 04 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Jan 2026 — ASSIGNED TO EXAMINER
- 07 Jan 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 07 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 08 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 08 Aug 2025 — NEW APPLICATION ENTERED